Pulmonary Disease Doctors in Corpus Christi, TX Accepting Medicare

8 Pulmonary Disease doctors found. Showing 1 - 8

Dr. Salim R Surani, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1224 3rd St Ste 6, Corpus Christi, TX 78404 Phone: 361-257-1427    Fax: 361-444-5362

Dr. Mohammed Ali, D.O. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7101 S Padre Island Dr, Corpus Christi, TX 78412 Phone: 361-452-8360

Lorenzo Martin, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1406 Martin Luther King Dr, Corpus Christi, TX 78401 Phone: 361-887-8811    Fax: 361-887-8874

Dr. Ramakrishna Chakilam, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6102 Parkway Dr, Suite 106, Corpus Christi, TX 78414 Phone: 361-226-1908    Fax: 361-332-4929

Dr. Alamgir Ahmad Khan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Ayers St, Corpus Christi, TX 78404 Phone: 361-885-7722    Fax: 361-885-7792

Rajeev Narang, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 S Alameda St, Corpus Christi, TX 78404 Phone: 361-884-2687    Fax: 361-884-3425

Dr. William Walter Burgin Jr., M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1702 Horne Rd, Corpus Christi, TX 78416 Phone: 361-884-8200    Fax: 361-882-6649

Dr. Mark Wilson Geneser, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 226 Oleander Ave, Corpus Christi, TX 78404 Phone: 361-882-3337

News Archive

Facts about heart disease for women

Many women don't worry about heart disease, or if they do, they are concerned it's something the men in their lives might develop.

Fresenius Medical Care's first-quarter net revenue up 13% to $2,882 million

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its results for the first quarter of 2010.

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

America's Prostate Cancer Organizations release shared perspective on screening and treatment

America's Prostate Cancer Organizations today released the full text of written testimony to the House Committee on Oversight and Government Reform. The Committee will be holding a hearing on "Prostate Cancer: New Questions About Screening and Treatment" on March 4, 2010.

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

Read more Medical News

› Verified 8 days ago